Home/Immuron/Michael G. (CEO)
MG

Michael G. (CEO)

Chief Executive Officer

Immuron

Immuron Pipeline

DrugIndicationPhase
TravelanTravellers' diarrhoea (ETEC)Commercial
ProtectynDigestive and liver health supportCommercial
ProIBSIrritable bowel syndrome symptom reliefCommercial
Immuron CDI CandidateClostridioides difficile infectionPhase 2
Immuron ETEC CandidatePrevention of ETEC‑related travellers' diarrhoeaPhase 2